首页|战丽彬教授治疗阿尔茨海默病痴呆的经验

战丽彬教授治疗阿尔茨海默病痴呆的经验

扫码查看
阿尔茨海默病痴呆(Alzheimer's disease dementia,ADD)是临床中最常见的痴呆类型,对患者本人、家庭、社会均带来严重的负担。针对阿尔茨海默病的药物临床Ⅲ期试验结果令人振奋,但对于阿尔茨海默病痴呆阶段的临床治疗,目前世界范围内尚缺乏针对性强且行之有效的药物。将中医药治疗的理念引入到阿尔茨海默病痴呆的临床治疗领域,可能会为该病的临床治疗提供新的方法。概述中医对ADD病因病机的源流及进展认识,总结战丽彬教授多年来对ADD治疗的学术思想和用药经验,并提供了经典个案分享,为中医药治疗ADD提供指导和参考。
ZHAN Libins Experience in Treating Alzheimers Disease Dementia
Alzheimer's disease dementia(ADD)is the most common type of dementia in clinical practice,which brings seri-ous burden to patients,their families and society.The results of phase Ⅲ clinical trials of drugs for Alzheimer's disease are excit-ing,but for the clinical treatment of ADD stage,there is still a lack of targeted and effective drugs in the world.Introducing the concept of traditional Chinese medicine into the clinical treatment of Alzheimer's disease may provide a new method for the clini-cal treatment of the disease.This paper summarized the source,flow and progress of TCM's understanding of the etiology and pathogenesis of ADD,summarized Professor ZHAN Libin's academic thoughts and medication experience in the treatment of ADD over the years,and provided classic case sharing to provide guidance and reference for TCM treatment of ADD.

ZHAN LibinAlzheimer's Diseasedementiasummary of experience

岳晓青、路童、王天娇、战丽彬

展开 >

禹城市人民医院,山东禹城 251200

辽宁中医药大学附属医院,辽宁沈阳 110032

辽宁中医药大学,辽宁沈阳 110847

战丽彬 阿尔茨海默病 痴呆 经验总结

2024

中华中医药学刊
中华中医药学会 ,辽宁中医药大学

中华中医药学刊

CSTPCD北大核心
影响因子:1.007
ISSN:1673-7717
年,卷(期):2024.42(12)